Latest news with #TANGO
Time of India
5 days ago
- Entertainment
- Time of India
Tango is about honesty and the trust in motion: Kruti Gandhi Sarda
It started with a melody that 'stuck with her'. 'Something about Tango kept pulling me back,' she says. Now, that fascination helped her bag the third place in the social competition category at the Indonesia Tango Championship Preliminaries 2025. Tired of too many ads? go ad free now 'WHEN I STARTED, TANGO WAS THE NICHE OF NICHES' Back then, no one knew tango. 'It wasn't even a niche,' Kruti says. 'It was the niche of niches. Maybe ten people in Mumbai danced occasionally. There were no local teachers, no thriving community, and no structured training. But something about the dance kept pulling me back,' she adds. Kruti, who was already a salsa dancer, says, 'Tango was different, unlike Salsa or Bachata, with their predictable beats and choreographed sequences. There is no set beat. You can pause, wait, breathe, and improvise. Every time you dance the same song, even with the same person, it's a new experience.' 'TANGO IS NOT JUST A DANCE FORM' Tango, she says, is like meditation for two. 'That emotional depth is why it's used in therapy, including for people with Parkinson's. It gives them stillness, presence and emotional stability. That's the power of Tango.' She then shares that Tango isn't gender-specific. 'It's role-centric,' Kruti says, adding, 'Anyone can lead and follow.' 'AS A DANCER, YOU NEED TO BE OPEN TO FEEDBACK' This year, Kruti went with five dancers to the Indonesian Tango Dance Championship, and four of them were her students. 'We were a close-knit group. That matters.' She says every competition pushes her further. 'You work harder. You show up better. You grow. But unlike social dancing, in competition, the rapport with your partner matters deeply. Tired of too many ads? go ad free now You have to be comfortable, but also open to feedback. You need a strong foundation of friendship, trust, and drive,' she says. 'YOU NEED PATIENCE TO MASTER TANGO' Building a Tango community in Bengaluru has been a labour of love. 'It's not a form built for instant gratification. In two months, you can feel confident dancing Bachata. But Tango, every layer you peel reveals more beneath it,' she says, comparing it to classical Indian dance, like Bharatanatyam. 'It demands time, discipline, and patience,' she adds. 'PEOPLE WERE SURPRISED INDIANS KNEW OF TANGO' When she first began travelling abroad to learn Tango, Kruti didn't see herself as doing something extraordinary. She says, 'I realised people were surprised that I am a Tango Dancer and that it is a form of art that's well known in India. Now I tell them, 'Come visit. See for yourself '.'
Globe and Mail
07-08-2025
- Business
- Globe and Mail
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that management will host a webcast and conference call for analysts and investors on Tuesday, August 12, 2025, at 4:30 p.m. ET, to discuss second quarter 2025 business and financial updates. The webcast will be available on the Investors & News section of Stoke's website at Research analysts who plan to join the call and participate in the Q&A session may register here to receive the dial-in details and a unique PIN. All other participants are invited to access the listen-only webcast by clicking here. An archived replay of the webcast will be available for at least 90 days following the event. About Stoke Therapeutics Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit
Yahoo
07-08-2025
- Business
- Yahoo
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates
BEDFORD, Mass., August 07, 2025--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that management will host a webcast and conference call for analysts and investors on Tuesday, August 12, 2025, at 4:30 p.m. ET, to discuss second quarter 2025 business and financial updates. The webcast will be available on the Investors & News section of Stoke's website at Research analysts who plan to join the call and participate in the Q&A session may register here to receive the dial-in details and a unique PIN. All other participants are invited to access the listen-only webcast by clicking here. An archived replay of the webcast will be available for at least 90 days following the event. About Stoke TherapeuticsStoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit View source version on Contacts Stoke Media & Investor Contacts: Dawn KalmarChief Communications Officerdkalmar@ 781-303-8302 Doug SnowDirector, Communications & Investor RelationsIR@ 508-642-6485 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
07-08-2025
- Business
- Business Wire
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2025 Business and Financial Updates
BEDFORD, Mass.--(BUSINESS WIRE)-- Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that management will host a webcast and conference call for analysts and investors on Tuesday, August 12, 2025, at 4:30 p.m. ET, to discuss second quarter 2025 business and financial updates. The webcast will be available on the Investors & News section of Stoke's website at Research analysts who plan to join the call and participate in the Q&A session may register here to receive the dial-in details and a unique PIN. All other participants are invited to access the listen-only webcast by clicking here. An archived replay of the webcast will be available for at least 90 days following the event. About Stoke Therapeutics Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit
Yahoo
26-03-2025
- Entertainment
- Yahoo
Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Check Back
There are spoilers ahead. You might want to solve today's puzzle before reading further! Check Back Constructor: Beth Rubin Editor: Amanda Rafkin HAITI (35A: Author Edwidge Danticat's birthplace) Edwidge Danticat's first book, Breath, Eyes, Memory (1994), was an Oprah's Book Club selection. Edwidge Danticat was born in Port-au-Prince, HAITI and moved to New York City as a young girl. Breath, Eyes, Memory began as an essay about her childhood in HAITI and expanded into a novel dealing with racial, linguistic, and gender identity. Edwidge Danticat's most recent book, We're Alone, was published in September of last year. TANGO (61A: Alejandra Mantinan and Aoniken Quiroga's dance) You can find multiple videos online of Alejandra Mantinan and Aoniken Quiroga dancing the TANGO. Here's a link to one to get you started. CROC (1A: Gator's cousin) When I see a mention of CROCs and gators together, I am reminded of helpful articles I've read that point out the differences between them. One of the differences is that a CROC typically has a stronger bite than a gator. Um ... I prefer not to be bitten by either one, to be honest. ELLA (14A: Jazz legend Fitzgerald) and ETTA (65A: "At Last" singer James) As a result of their crossword-friendly four-letter names, we see references to ELLA Fitzgerald and ETTA James in the crossword on a regular basis. It was fun to see them appear together today. HALLE (15A: Oscar winner Berry) In 2001, HALLE Berry won an Oscar (Academy Award) for Best Actress for Monster's Ball. ALS (48A: Pulitzer Prize winner Hilton) Hilton ALS is a writer and theater critic. He won a Pulitzer Prize for Criticism in 2017, "For bold and original reviews that strove to put stage dramas within a real-world cultural context, particularly the shifting landscape of gender, sexuality and race." MESA (51A: Costa ___, California) Costa MESA, which is Spanish for "coastal tableland," is located in Orange County in southern California. EASEL (55A: Means of support for an artist) This is a fun clue, because when I read "means of support," my first thought was financial support. Instead, the support here is an EASEL, a stand that provides physical support for an artist's work. PETE (67A: Folk singer Seeger) We saw PETE Seeger in the puzzle just six days ago. PLOT (6D: One might have a twist) This reminded me of last Wednesday's puzzle, which was titled "PLOT Twist." PLANTAIN (10D: Fruit in kelewele) Kelewele is a Ghanian dish also known as Spicy Fried PLANTAINs. HAL (15D: Actor Holbrook) In 1954, HAL Holbrook (1925-2021) developed a one-man stage show called Mark Twain Tonight! He portrayed Mark Twain for more than 60 years, winning a Tony Award in 1966 for Best Actor in a Play. CHAI TEA (31D: Beverage often flavored with cardamom) Yesterday we saw the separate answers CHAI and TEA in the puzzle, and today they have joined forces. Some people are bothered by the expression CHAI TEA, because since CHAI is a Hindi word for TEA, the phrase basically means TEA TEA. However, I recently read a book in which one of the characters opened a TEA shop, and about this very thing, he said, "As long as people are drinking TEA, it doesn't bother me what they choose to call it." I like that approach. PAM (40D: "Jackie Brown" actress Grier) Jackie Brown is a 1997 crime movie directed by Quentin Tarantino. The movie is based on Elmore Leonard's 1992 book, Rum Punch. PAM Grier stars as the title character, a flight attendant who smuggles money between the United States and Mexico. YOU (45D: "___ become strong by doing the things ___ need to be strong for") "YOU become strong by doing the things YOU need to be strong for," is an Audre Lorde quote from her book, Sister Outsider: Essays and Speeches. This is a lovely way to clue the word YOU. TAP (61D: Dance like the Nicholas Brothers) Fayard (1914-2006) and Harold (1921-2000) had a dancing style sometimes called acrobatic dancing, which combined elements of TAP, ballet, and acrobatics. The brothers taught master classes in TAP dance at Harvard and Radcliffe Universities. Do yourself a favor and spend three minutes of your day enjoying the Nicholas Brothers performance in the 1943 movie, Stormy Weather. FILL IN THE BLANK (19A: Test format) RIGHT AS RAIN (37A: Perfectly fit and well) VIRTUAL REALITY (57A: Simulated 3D experience used in some video games) CHECK BACK: The BACK (last) word of each theme answer can be paired with the word CHECK to form a new phrase: BLANK CHECK, RAIN CHECK, and REALITY CHECK. The theme of this puzzle made me think that perhaps I'll take a RAIN CHECK on doing a REALITY CHECK. However, I won't be writing a BLANK CHECK! It's an interesting theme with a nice set of theme answers. Thank you, Beth, for this enjoyable puzzle. USA TODAY's Daily Crossword Puzzles Sudoku & Crossword Puzzle Answers This article originally appeared on USA TODAY: Crossword Blog & Answers for March 26, 2025 by Sally Hoelscher
